Neurological Disorders Therapies Downloads
-
CanaQuest Overview_Q4 2023
CanaQuest Medical (CANQF), a clinical-stage, life sciences company, is focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is prioritizing treating neurological conditions such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder "PTSD," including ...
-
CanaQuest Medical Corp Overview - A Clinical-Stage Life Sciences Company - Brochure
CanaQuest Medical (CANQF), a clinical-stage, life sciences company, is focused on drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is prioritizing treating neurological conditions such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder "PTSD," including addiction. Preclinical ...
-
CanaQuest Medical Corp - Brochure
CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including ...
-
ViennaLab - Model HLA-A3101 & HLA-B1502 - Carbamazepine - Brochure
Carbamazepine is an anticonvulsant commonly prescribed for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia, but can also cause severe cutaneous adverse reactions in patients who are positive for variant alleles HLA-A*31:01 or HLA-B*15:02. ViennaLab RealFast™ Assays discriminate between the presence or absence of these alleles and thus are a tool to prevent ...
-
Cilase - Model Cilase - Therapeutic Enzymes for Pancreatic Insufficiency Brochure
Cilase is a recombinant lipase enzyme developed as an oral, non-systemic enzyme replacement therapy for the treatment of exocrine pancreatic insufficiency (EPI) and other chronic digestive disorders. The therapeutic effect of Cilase can be supported by a complementary administration of a protease and an amylase. ...
By Cilian AG
-
Simplifi - Model ACCEL+ and Accel - Neuromodulation System - Brochure
The SIMPLIFI Neuromodulation Solutions Platform offers uncompromising consulting, manufacturing, customization and engineering simplicity for advanced research and new product development. Lower the risk. Speed the success of your novel therapy or next generation device. The platform consists of ACCEL+ and ACCEL, two neuromodulation systems that help turn concepts into clinical and commercial ...
-
BAN2401 - Lecanemab - Alzheimer Disease Drug Brochure
In Alzheimer’s disease soluble, toxic amyloid beta aggregates are believed to contribute to the neurodegenerative process. Lecanemab, a anti amyloid-beta protofibril antibody, selectively binds to these forms of amyloid beta and eliminates them. The antibody’s unique profile is highly selective for amyloid beta oligomers/protofibrils in the brain. BioArctic’s belief is that ...
By BioArctic AB
-
Risperdal Consta - Benzisoxazole Derivative Tablets - Brochure
Risperdal Consta (risperidone) is a benzisoxazole derivative with potent combined serotonin 5HT2A and dopamine D2 receptor-blocking properties. It is an effective atypical antipsychotic that is well tolerated, based on extensive clinical experience including long-term use. The authorised formulation of Risperdal Consta is a prolonged-release formulation for intramuscular (i.m.) injection ...
By Alkermes
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you